Arax Advisory Partners’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.67K Sell
732
-856
-54% -$10.1K ﹤0.01% 4347
2026
Q1
$1.26K Buy
+1,588
New +$14.2K ﹤0.01% 3234
2025
Q4
Sell
-421
Closed -$5.98K 4153
2025
Q3
$5.98K Buy
+421
New +$5.56K ﹤0.01% 2812
2025
Q2
Sell
-52
Closed -$775 3062
2025
Q1
$775 Buy
+52
New +$893 ﹤0.01% 2394

Other funds holding CCRN

Arax Advisory Partners's CCRN Position: Q2 2026 in Review

Arax Advisory Partners reduced its Cross Country Healthcare (CCRN) stake by 54% in Q2 2026, selling an estimated $10.1K and leaving 732 shares worth $9.67K. The position accounts for ﹤0.01% of the portfolio, ranked #4347.

Arax Advisory Partners first reported a position in CCRN in Q1 2025 and has held it in 4 quarters since. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Arax Advisory Partners held 732 shares of Cross Country Healthcare worth $9.67K as of Q2 2026.
  • Arax Advisory Partners sold 856 Cross Country Healthcare shares in Q2 2026, an estimated $10.1K.
  • Cross Country Healthcare made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4347 holding.
  • Arax Advisory Partners first reported a position in Cross Country Healthcare in Q1 2025 and has held it in 4 quarters since.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.